[PDF][PDF] Benefits of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Sudanese Patients and the Effective Number of Cycle and Dose
…, SAM Babkeir, R Omer, R Yasin, KEA Abaker… - researchgate.net
Background: Prostate cancer remains the most common cancer in men worldwide and in
Sudanese people. The initial treatment of choice for prostate cancer is androgen deprivation. If …
Sudanese people. The initial treatment of choice for prostate cancer is androgen deprivation. If …
Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)
…, YA Suleiman, ROI Alameen, KEA Abaker… - Clinical …, 2019 - ncbi.nlm.nih.gov
Background Prostate cancer remains the most common cancer in men worldwide and in
Sudanese people. The initial treatment of choice for prostate cancer is androgen deprivation. If …
Sudanese people. The initial treatment of choice for prostate cancer is androgen deprivation. If …